AORT: Form 144 filed to sell 6,563 common shares on NYSE

Rhea-AI Filing Summary

John E. Davis filed a Form 144 notice to sell up to 6,563 shares of common stock, with an aggregate market value of $300,968.02. The shares are slated for sale on or after 11/13/2025 on the NYSE through Fidelity Brokerage Services LLC.

The securities were acquired via restricted stock vesting from the issuer on 11/10/2025 (3,282 shares) and 11/11/2025 (3,281 shares), recorded as compensation. The filing also lists a recent sale by the same person on 11/11/2025 of 3,373 shares for gross proceeds of $150,499.55. Shares outstanding were 47,374,939; this is a baseline figure, not the amount being sold.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	6563	300968.02	47374939	11/13/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/10/2025	Restricted Stock Vesting	Issuer			3282	11/10/2025	Compensation
Common	11/11/2025	Restricted Stock Vesting	Issuer			3281	11/11/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
John E. Davis 1655 Roberts Boulevard, NW Kennesaw GA 30144	Common	11/11/2025	3373	150499.55

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does AORT's Form 144 filing disclose?

It states that John E. Davis plans to sell up to 6,563 common shares on or after 11/13/2025 on the NYSE via Fidelity Brokerage Services LLC.

How many AORT shares are proposed for sale and what is the value?

The filing lists 6,563 shares with an aggregate market value of $300,968.02.

When and where will the AORT shares be sold?

The approximate sale date is 11/13/2025 on the NYSE.

How were the shares to be sold acquired?

They were acquired via restricted stock vesting on 11/10/2025 (3,282 shares) and 11/11/2025 (3,281 shares) as compensation.

Were there recent sales by the same person in the last 3 months?

Yes. On 11/11/2025, 3,373 shares were sold for $150,499.55 in gross proceeds.

How many AORT shares are outstanding?

The filing lists 47,374,939 shares outstanding.